August 21st, 2026
The retina is a part of the central nervous system, and as such is subject to a variety of forms of age-related neurodegeneration, culminating in conditions such as macular degeneration. The chronic inflammation characteristic of old age is just as important to neurodegeneration in the retina just as it is in the brain. Inflammatory signaling, necessary and useful in the short term, becomes disruptive to cell and tissue function when sustained over the long term. The causes of chronic inflammation are manifold, a list of much of what goes wrong in cellular biochemistry with age, but most research is focused instead on how this maladaptive inflammatory response is regulated. Development of anti-inflammatory therapies does not focus on removing the cause of inflammatory signaling - which at the end of the day will probably require achieving actual rejuvenation, repair of the cell and tissue damage that causes aging - but instead aims to sabotage the controlling mechanisms of the inflammatory response. This works, but as existing therapies demonstrate, it is hard to sabotage unwanted inflammation without also sabotaging necessary inflammation. Whether there are as yet unexplored approaches that can achieve that goal remains to be seen.
